Christine Welch

Health Technology

Consumer Services

Profile

Christine Welch worked as a Senior Director at Gilead Sciences, Inc. She then worked as a Senior Director-Regulatory Affairs at Achaogen, Inc. from 2011 to 2012.
Prior to that, she worked as a Senior Director-Regulatory Affairs at Alexza Pharmaceuticals, Inc. from 2008 to 2011.
Welch received an undergraduate degree from The University of Liverpool and a graduate degree from Newcastle University.

Former positions of Christine Welch

Companies	Position	End
ALEXZA PHARMACEUTICALS, INC.	General Counsel	31/12/2010
GILEAD SCIENCES, INC.	Corporate Officer/Principal	-
ACHAOGEN	General Counsel	-

See the detail of Christine Welch's experience

Training of Christine Welch

The University of Liverpool	Undergraduate Degree
Newcastle University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christine Welch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GILEAD SCIENCES, INC.	Health Technology

Private companies	2
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology
Alexza Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.	Health Technology